John L. Brottem Insider Profile
11 Followers
John L. Brottem, General Counsel at Alamar Biosciences, Inc., holds 29.00K shares in Alamar Biosciences, Inc. (Ticker: ALMR), holds 87.47K shares in Outset Medical (Ticker: OM).
John L. Brottem Alamar Biosciences, Inc. (ALMR)General Counsel
Alamar Biosciences, Inc. (ALMR)
General Counsel
Ranked #226 out of 109,349 Corporate Insiders
Profitable Transactions
24 out of 28 Profitable Transactions
Average Return
+49.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John L. Brottem holds in companies
Most Profitable Insider Trade
The most profitable trade made by John L. Brottem
John L. Brottem's Trading History
Alamar Biosciences, Inc.
Sep 16, 2026
General Counsel
Uninformative Buy
―
$887.40K
Outset Medical
Aug 18, 2026
GC
Informative Sell
11.55K
$352.52K
List of latest transactions for each holding click on a transaction to see John L. Brottem's performance on stock
You May Also Like
John L. Brottem insider profile FAQ
What is the percentage of profitable transactions made by John L. Brottem?
The percentage of profitable transactions made by John L. Brottem is 86%.
What is the average return per transaction made by John L. Brottem?
The average return per transaction made by John L. Brottem is 49.60%.
What stocks does John L. Brottem hold?
John L. Brottem holds: ALMR, OM stocks.
What was John L. Brottem’s latest transaction?
John L. Brottem latest transaction was an Uninformative Buy of ―.
What was John L. Brottem's most profitable transaction?
John L. Brottem’s most profitable transaction was an Informative Sell of OM stock on August 17, 2023. The return on the trade was 95.20%.
What is John L. Brottem's role in Alamar Biosciences, Inc.?
John L. Brottem's role in Alamar Biosciences, Inc. is General Counsel.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.